Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin.
about
Identification of cells initiating human melanomasImmunization with a mimotope of GD2 ganglioside induces CD8+ T cells that recognize cell adhesion molecules on tumor cellsActivated leukocyte cell adhesion molecule in breast cancer: prognostic indicatorCell Adhesion Molecules and Ubiquitination-Functions and SignificanceMolecular basis for the homophilic activated leukocyte cell adhesion molecule (ALCAM)-ALCAM interactionALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesionsMEMD/ALCAM: a potential marker for tumor invasion and nodal metastasis in esophageal squamous cell carcinomaMolecular isolation and characterization of a soluble isoform of activated leukocyte cell adhesion molecule that modulates endothelial cell functionInfluence of monolayer, spheroid, and tumor growth conditions on chromosome 3 gene expression in tumorigenic epithelial ovarian cancer cell lines.Expression of the embryonic stem cell transcription factor SOX2 in human skin: relevance to melanocyte and merkel cell biologyExpression of SC1, a cell adhesion molecule, promotes the metastatic activities of the Gallus gallus lymphoblastoid cell line MDCC-MSB1 derived from Marek's disease.Activated leukocyte cell adhesion molecule expression and shedding in thyroid tumors.Epigenetic regulation of microRNA genes and the role of miR-34b in cell invasion and motility in human melanomaCharacterization of the intestinal cancer stem cell marker CD166 in the human and mouse gastrointestinal tractRelevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients.Enhanced immunoPET of ALCAM-positive colorectal carcinoma using site-specific ⁶⁴Cu-DOTA conjugation.ALCAM regulates motility, invasiveness, and adherens junction formation in uveal melanoma cells.Identification of CD166 as a surface marker for enriching prostate stem/progenitor and cancer initiating cellsAdhesion, migration and communication in melanocytes and melanoma.Clinico-pathological features of relapsing very thin melanoma.Dynamics of cell interactions and communications during melanoma development.Increased expression of melanoma stem cell marker CD271 in metastatic melanoma to the brain.NF-kappaB P50/P65 hetero-dimer mediates differential regulation of CD166/ALCAM expression via interaction with micoRNA-9 after serum deprivation, providing evidence for a novel negative auto-regulatory loop.Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanomaALCAM: Basis Sequence: MouseCytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancerThe usefulness of c-Kit in the immunohistochemical assessment of melanocytic lesionsImmunohistochemistry in melanocytic proliferative lesions.Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.SC1, an immunoglobulin-superfamily cell adhesion molecule, is involved in the brain metastatic activity of lung cancer cells.Expression and Role of CD166 in the Chronic Kidney Disease.Activated leukocyte cell adhesion molecule (ALCAM/CD166): signaling at the divide of melanoma cell clustering and cell migration?Enhanced growth inhibition of osteosarcoma by cytotoxic polymerized liposomal nanoparticles targeting the alcam cell surface receptor.Quantitative analysis of surface plasma membrane proteins of primary and metastatic melanoma cells.Enhanced Cross-Linking of Diazirine-Modified Sialylated Glycoproteins Enabled through Profiling of Sialidase Specificities.Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastasesDNA microarray analyses of melanoma gene expression: a decade in the mines.Activated leukocyte cell adhesion molecule: a novel biomarker for breast cancer.Cancer stem cells and human malignant melanoma
P2860
Q24622896-AC0F773F-E24E-4703-893C-CFF38F8F8534Q24648424-CD9DD6DA-E970-4264-9CA2-4DBBAEA96E80Q24806155-C6D1290A-2DF3-4492-9736-6B59AE77B723Q26771983-49261B3C-53E2-4DC4-AEB6-1F9E22D6A651Q28212934-71781352-7409-4F98-B0BA-ADC3A20EB0BBQ28217430-E2B518F4-93FF-4D5D-BA83-9738C1A1F737Q28262234-CDD4B743-B0A4-4B03-B528-645B8E62F3F1Q28288857-421D3F68-3A36-4D21-B73D-01DFF7587D19Q33358552-A2C8DFC4-B2B1-4DCC-941A-574148C21D63Q33597213-1A383945-AE0A-4A0F-9814-1DB4A5098F81Q33823820-6C3DB85E-A8C5-483F-A583-4952BDB7C6A7Q33833972-21E3080E-5CEB-4F3D-88EF-8F95A2D9E7F3Q34031613-53D2DED6-73DB-4D52-B8F4-A6C297160BEFQ34136852-58949C15-C289-4F38-A54E-03D6B954BF88Q34220083-71821794-B3E2-4F70-802D-2786F15E7CACQ34313174-176F3F32-E3D9-4CF0-A181-C944877F2349Q34321331-0066D5BA-BED8-4057-BF29-0AF60C4C7296Q34374335-AFB93B1B-7D1B-401B-9195-0EF8E075569CQ34418722-7029B666-8001-468F-A929-A51D536576E6Q34448369-AFA509FB-E39C-45B5-BB2C-48B6E5CD7344Q34720575-4F17BEBE-BE7A-487A-A73E-6DA592D11F7AQ35038430-7CEF9104-CD04-4881-ADFE-51570CBC437AQ35174757-E3C3E7F8-78C7-4102-882D-2888C6516FEBQ35234354-6EFBFA0F-B7C6-41FD-A2F8-CC8C9CC1EA73Q35609716-BF763A0F-0BA5-4E6F-99C5-6CBEE9163953Q35769956-9DBDC4D7-3523-415E-A160-B708BF824FF8Q35771115-5C9D8E79-E408-447E-AD01-99E68CE045B9Q35798186-C025569E-F8BF-4193-B43A-79BE32256DFCQ35809642-B5CF7CD9-1D78-4F74-8F74-054411415464Q36010284-A2A54039-5A00-4424-AA3F-D9360F0E23FBQ36085675-DBCC15F0-9095-451A-8130-4621F7F59666Q36175628-DF125085-3A40-4C01-85FB-86E73CD7EC2AQ36178357-82DA4548-BC4B-46E2-BDD5-41577ABB39C4Q36248528-B869E05B-3352-45B0-8385-48FC656DF65DQ36440727-EC18ADA8-913B-43BE-980D-A7825D4C879CQ36514827-00B7349B-26D3-428C-AA6D-8A759618924EQ36747524-EE6715FB-6C36-4DC7-80BE-29C1B918CA6CQ36970643-E5BC4C66-DC47-41B2-8B3A-F24D35B2A01DQ37095851-991A5B68-CF30-42DC-82A7-2A327BF461D1Q37114128-5EA95EB1-F054-4DE0-8C44-86D3390F1E9D
P2860
Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Activated leukocyte cell adhes ...... alignant melanoma of the skin.
@en
Activated leukocyte cell adhes ...... alignant melanoma of the skin.
@nl
type
label
Activated leukocyte cell adhes ...... alignant melanoma of the skin.
@en
Activated leukocyte cell adhes ...... alignant melanoma of the skin.
@nl
prefLabel
Activated leukocyte cell adhes ...... alignant melanoma of the skin.
@en
Activated leukocyte cell adhes ...... alignant melanoma of the skin.
@nl
P2093
P2860
P1476
Activated leukocyte cell adhes ...... alignant melanoma of the skin.
@en
P2093
G N van Muijen
H P Bloemers
J J van den Oord
L C van Kempen
U H Weidle
P2860
P304
P356
10.1016/S0002-9440(10)64943-7
P407
P577
2000-03-01T00:00:00Z